Givinostat
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Structure evaluation coupled with all-atom molecular dynamics and advanced quantum mechanical DFT revealed kaempferol as a potent binding flavonol for the epigenetic-target HDAC9.
Journal: Journal of biosciences
Published: May 08, 2026
Treatment advances for Duchenne muscular dystrophy.
Journal: Current opinion in pediatrics
Published: April 01, 2026
Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update.
Journal: Expert opinion on pharmacotherapy
Published: March 30, 2026
Corrigendum to "Givinostat rescues folding of cystathionine beta-synthase and ameliorates murine homocystinuria" [Biochem. Pharmacol. 239 (2025) 117079].
Journal: Biochemical pharmacology
Published: February 28, 2026
Corticosteroid treatment in Duchenne muscular dystrophy.
Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Published: December 14, 2025
Cardiac surveillance in the era of Duvyzat: do we need to do more?
Journal: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
Published: December 09, 2025
Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model.
Journal: Biological & pharmaceutical bulletin
Published: November 30, 2025
Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: November 24, 2025
The Diverse Effect of HDAC Inhibitors: Sodium Butyrate and Givinostat on Microglia Polarization After Hypoxia-Ischemia In Vitro.
Journal: International journal of molecular sciences
Published: November 18, 2025
Targeting autophagy in Duchenne muscular dystrophy: mechanistic insights and emerging therapeutic strategies.
Journal: Journal of medical genetics
Published: October 02, 2025
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications.
Journal: Current therapeutic research, clinical and experimental
Published: August 07, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 22, 2025
Last Updated: 06/30/2026